1st Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.
Foreign entity interest: Pierre Fabre SA and Pierre Fabre Foundation have an interest in drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
| STEPHEN HOLLAND | — |
| LAUREN ALEXANDRA MISH | — |
| ZACHARY PFISTER | — |
| ADAM STEINMETZ | — |
| DEEMA TARAZI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.